ACRS
Aclaris Therapeutics, Inc. · Healthcare
10% owner Braden Michael Leonard sold $1.4M of Aclaris Therapeutics, Inc.
Sold$1,359,000
$4.53Price
300,000Shares
−2%Stake
What ACRS did after the filing
- The stock from Tue, Apr 28 open, $4.20
- −2.4%
- S&P 500, same days
- +1.9%
Measured over 30 trading days, to the Jun 10 close.
Traded Thu, Apr 23. Filed Mon, Apr 27, 7:27 PM ET, after the close. Returns use the Apr 28 open and the Jun 10 close. Not investment advice.